Menu

Image of the Day: Black-Eyed Rage

When defensive, guppies display a warning sign to their counterparts. 

Jun 6, 2018
Sukanya Charuchandra

A black-eyed guppy (Poecilia reticulata) defends a morsel of food from its calmer, silver-eyed counterpart. ROBERT HEATHCOTE UNIVERSITY OF EXETERIn a study published on June 4 in Current Biology, researchers report that Trinidadian guppies (Poecilia reticulata) swiftly alter their iris color from silver to black when behaving aggressively towards smaller guppies. “You’ll see these little angry fish swimming over food patches, attacking anything coming over them,” Robert Heathcote, a coauthor on the paper, tells The Atlantic

Black- and silver-eyed guppies (Poecilia reticulata) feed on a food patch. ROBERT HEATHCOTE UNIVERSITY OF EXETER

Heathcote’s team conducted behavioral trials using smaller, guppy-like robots with black or silver irises to see how larger guppies would respond to the eye color. The researchers found that when guarding food, the black-eyed, smaller imposters attracted larger, blacker-eyed competitors. The researchers believe the fish show their “honest” hostility only if they can be dominant over the smaller variants.

R.J.P. Heathcote et al., “Dynamic eye colour as an honest signal of aggression,” Curr Biol, doi:10.1016/j.cub.2018.04.078, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.